It was a financial investment in a tobacco company that helped lead to the downfall of Brenda Fitzgerald, who until Wednesday was the director of the Centers for Disease Control and Prevention.

For many in the public health community, the notion that the head of the CDC held shares of a company in an industry that has been so anathema to the agency’s mission was shocking.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Sadly, not uncommon. Obama appointed FDA Commissioner Margaret Hamburg still had stock options from her board days at Henry Schein – a dental products distributor – when she took down an FDA website warning about mercury health impacts from dental amalgam – and only recused herself at the last minute before its most curious classification, requiring no warnings to patients, but warnings from manufacturers to dentists. So there is no recourse for those who are harmed by it. People with a handful of fairly common gene types are more susceptible to harm, and it is being banned and restricted in a growing number of other nations. Hamburg was thanked profusely in a letter by Henry Schein. If ethicists were baffled, we never heard about it in the media. Which did not report it in the first place. Also curious.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy